Anixa Biosciences Inc (ANIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
04-2009 | 01-2009 | 10-2008 | 07-2008 | 04-2008 | |
Sales | 263 | 374 | 963 | 882 | 165 |
Cost of Goods | 4 | 20 | 11 | 35 | 37 |
Gross Profit | 259 | 355 | 953 | 847 | 128 |
Operating Expenses | 1,641 | 1,756 | 1,541 | 1,624 | 2,144 |
Operating Income | -1,378 | -1,382 | -578 | -741 | -1,978 |
Other Income | 34 | 7 | 12 | 12 | 137 |
Pre-tax Income | -1,344 | -1,375 | -566 | -729 | -1,841 |
Net Income Continuous | -1,344 | -1,375 | -566 | -729 | -1,841 |
Net Income | $-1,344 | $-1,375 | $-566 | $-729 | $-1,841 |
EPS Basic Total Ops | -0.25 | -0.25 | -0.25 | -0.25 | -0.25 |
EPS Basic Continuous Ops | -0.24 | -0.26 | -0.10 | -0.14 | -0.36 |
EPS Diluted Total Ops | -0.25 | -0.25 | -0.25 | -0.25 | -0.25 |
EPS Diluted Continuous Ops | -0.24 | -0.26 | -0.10 | -0.14 | -0.36 |
EBITDA(a) | $-1,376 | $-1,380 | $-578 | $-739 | $-1,975 |